Swiss should intensify cooperation with Covax, say experts
Some of the poorest countries in the world currently have as little as 0.1 Covid vaccine doses per 100 inhabitants, the SonntagsZeitung reported.
Keystone / Antonio Dasiparu
To effectively fight the global pandemic, rich countries like Switzerland should donate their surplus Covid-19 vaccines to poorer countries immediately, says Thomas Cueni, president of the International Federation of Pharmaceutical Manufacturers and Associations.
This content was published on
2 minutes
swissinfo.ch/gw
العربية
ar
خبراء: يجب على سويسرا تكثيف التعاون مع مبادرة “كوفاكس” العالمية
“We won’t get out of the pandemic unless everyone is vaccinated,” Cueni told the SonntagsZeitung newspaper, adding that a problem with distribution – and not production – of the vaccine was preventing poorer countries from inoculating their populations.
Pharmaceutical companies from Europe to Asia are capable of manufacturing 11 billion doses of the Covid vaccine by the end of 2021, said the Swiss national, who sits on the coordination committee of the Covax Initiative aimed at guaranteeing universal access to the vaccine.
“This would be enough to vaccinate the world’s adult population, if the vaccines were distributed fairly.”
While Switzerland has purchased enough vaccines for its entire population and approved vaccination for adolescents, Haiti has less than 0.1 vaccine doses per 100 inhabitants, the newspaper reported. Many countries in Africa, Asia and the Middle East suffer from a similar lack of vaccines.
“It’s shocking that certain rich countries have started vaccinating 12- to 16-year-olds, while many poor countries don’t even have vaccines for vulnerable populations,” said Cueni.
Unused vaccines set to expire
Although the Swiss government pledged on June 30 to donate four million doses of the Astra Zeneca vaccine to Covax, to date none have been delivered, Cueni pointed out. A spokesperson for the Federal Office of Public Health told the SonntagsZeitung work was ongoing to implement the donation.
“Switzerland should intensify its cooperation with Covax and get even more involved,” said epidemiologist Marcel Tanner, president of the Swiss Academies of Arts and Sciences.
Greater distributive justice was all the more urgent as millions of vaccine doses sitting unused in rich countries will soon expire, said Tanner, who added that these should be donated to countries in need without delay.
Popular Stories
More
Swiss Abroad
An eye-opening guide to Switzerland’s ear-splitting sirens
Consumer group files legal complaint against Swiss shoemaker On
This content was published on
The consumer affairs bureau of French-speaking Switzerland has filed a legal complaint against On accusing it of greenwashing.
This content was published on
Thomas Schinecker, CEO of Swiss pharma firm Roche, has dismissed fears that sales targets would be under threat by US tariffs.
This content was published on
Researchers are asking the Swiss public for help in naming two newly discovered Swiss fish species of the genus Barbatula.
Science alliance warns against Swiss government’s cost-cutting plans
This content was published on
An alliance of research and science institutions have warned of dire consequences if the Swiss government goes ahead with its austerity package.
Accidents during leisure time on the rise in Switzerland
This content was published on
IN 2024 more people had accidents during leisure time than in the previous year. Some 26% of all sports accidents happened playing football.
This content was published on
Apple's iPhones have gained further market share in Switzerland. Around half of all smartphone owners used a model from the US tech giant last year.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
In the vaccine race, can COVAX help poorer countries catch up?
This content was published on
COVAX expects to start rolling out Covid-19 vaccines to poorer countries at the end of February. Can it really help them catch up?
Swiss living in Covid-19 hotspots unable to get Covid vaccine
This content was published on
The head of the Organisation of the Swiss Abroad has called on the government to ensure that expatriate Swiss citizens get access to Covid vaccines.
Switzerland clears Pfizer/BioNTech vaccine for 12 to 15-year-olds
This content was published on
The Swiss health regulator Swissmedic has approved the use of the Pfizer/BioNTech vaccine for children aged as young as 12.
Latest COVAX funding drive gathers over CHF2 billion
This content was published on
At an online summit of the GAVI allianceExternal link on Wednesday, attended by Swiss President Guy Parmelin, a total of CHF2.16 billion and 54 million additional vaccine shots were pledged by dozens of countries to the COVAX vaccine-sharing pool. The COVAX mechanism, which has distributed 77 million doses to 127 countries, aims to accelerate access…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.